on VALNEVA (EPA:VLA)
Valneva at the 25th World Vaccine Congress in Washington
Valneva, a company specializing in vaccines, has announced its participation in the 25th World Vaccine Congress in Washington, D.C. The event will be held from March 31 to April 2, 2026. CEO Thomas Lingelbach and other team members will lead sessions.
On April 1st, Susanne Eder-Lingelbach will present the results of the chikungunya vaccine studies. In addition, Valneva and Instituto Butantan have launched a pilot vaccination campaign in Brazil.
Dr. Juan Carlos Jaramillo will participate in a roundtable discussion on vaccines against chikungunya and mosquito-borne diseases. Valneva hopes to establish new contacts at the congress.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALNEVA news